AUS
NZ
UK
CA
USA
IND
Healthcare
Health Sector Pressure Leads ASX Decline
September 11, 2025 04:03 PM AEST| By SamHighlights,ASX health sector dragged market lower,Wall Street strength lifted global sentiment,AI-linked stocks attracted major attention,The,ASX 200,began the session under pressure as health companies weighed heavily on the broader index. Among tho...
ASX 200 Spotlight: 4DMedical (ASX:4DX) Redefines Lung Imaging with Breakthrough Technology
September 11, 2025 03:50 PM AEST| By SamHighlights,4DMedical gains traction with regulatory approval in the US,Cutting-edge imaging transforms how lungs are examined globally,Rising interest reflects biotechnology’s growing role in the,ASX stock market,The,ASX 200,continues to showcase inn...
PolyNovo Strengthens Chair Stake Amid ASX 200 Attention: Insights into Recent Share Movements
September 11, 2025 01:18 PM AEST| By SamPolyNovo chair increases shareholding, highlighting active insider involvement and ASX 200 positioning.
A Deep Dive into Healthcare Innovation and Market Strength within the ASX 200
September 11, 2025 10:13 AM AEST| By SamResMed (ASX:RMD) leads in healthcare innovation with devices and SaaS solutions, securing its role within the ASX 200 and shaping long-term sector resilience.
ASX 200 Spotlight: Ramsay Health Care Faces Questions as Biotech
September 10, 2025 03:57 PM AEST| By SamHighlights,ASX queries Ramsay Health Care after post-results market reaction,Biotech sector sees strategic updates and funding developments,Healthcare and life sciences firms in focus ahead of AGM season,The,ASX 200,often captures the mood of the bro...
Pathkey.AI (ASX:PKY) Expands TrialKey Insights: Transforming Clinical Trial Predictions
September 09, 2025 04:07 PM AEST| By SamHighlights,Pathkey.AI (ASX:PKY) strengthens its TrialKey platform with fresh validations.,Clinical trial predictions align with real-world biotech outcomes.,Broader applications expand to insurers, biotech innovators, and trial sponsors.,In the fast-...
OncoSil Medical Ltd’s New ASX Quotation What It Means for the ASX 200 Landscape
September 09, 2025 03:32 PM AEST| By SamHighlights,OncoSil Medical Ltd announces quotation of new securities on the ASX.,The move strengthens the company’s operational and financial strategy.,Investors explore the wider impact across the ASX stock market.,The Australian Securities Exchange...
Telix Surges While Broader ASX 200 Market Softens
September 09, 2025 02:46 PM AEST| By SamHighlights,Telix (ASX:TLX) advances on regulatory progress in the healthcare sector,BHP (ASX:BHP) navigates settlement obligations linked to international litigation,Life360 (ASX:360) continues its growth momentum within the technology space,The,ASX...
Biotech Stocks on the ASX: A Deep Guide for 2025
September 08, 2025 04:07 PM AEST| By Team Kalkine MediaAustralia’s biotechnology sector has grown from a niche space into a bona fide growth engine for the local market. From blood-plasma therapeutics to radiopharmaceuticals, implantable medical devices, wound-regeneration scaffolds, and rare-disease dru...
How 4DMedical’s Imaging Innovation Expands Across Hospitals and Screening Programs with ASX 200 Relevance
September 08, 2025 03:56 PM AEST| By Sam4DMedical (ASX:4DX) expands its lung imaging technology across hospitals and global screening programs, enhancing early detection, preventive healthcare, and positioning itself as a leader in respiratory innovation.
Alterity Therapeutics Placement Reframes Liquidity Across All Ordinaries
September 08, 2025 03:41 PM AEST| By SamHighlights,Short-selling backdrop set against a fresh equity placement by Alterity Therapeutics (ASX:ATH),Plain-English view of ATH434, pipeline priorities, and planned use of proceeds,Practical questions for tracking short interest, borrow supply, a...
CSL (ASX:CSL) in Focus A Deep Dive into Its Role in Healthcare and the ASX 200 Today
September 08, 2025 02:47 PM AEST| By SamHighlights,CSL anchors the healthcare space within the S&P/ASX 200 index.,The company operates through CSL Behring, CSL Seqirus, and CSL Vifor.,Strong global presence across plasma therapies, vaccines, and renal treatments.,Prominent inclusion among...
Imagion Biosystems (ASX:IBX) Advances MagSense Imaging Agent as Part of Phase 2 HER2 Breast Cancer Trial
September 08, 2025 01:55 PM AEST| By SamImagion Biosystems (ASX:IBX) advances MagSense imaging agent manufacturing for Phase 2 HER2 breast cancer trial, strengthening biotech presence in the ASX 200 and Australian stock market.
Memphasys (ASX:MEM) Expands Felix Fertility Device Reach Across MENA: A Boost for ASX 200 Market Dynamics
September 08, 2025 01:18 PM AEST| By SamMemphasys secures strategic MENA distribution for its Felix device, highlighting growth potential in ASX 200 landscape and global fertility technology sector.
All Ordinaries EZZ Life Science (ASX:EZZ) Faces Market Pressure
September 07, 2025 09:02 PM AEST| By SamHighlights,EZZ Life Science Holdings reported earnings that show a disconnect between statutory and free flow.,Share dilution reduced earnings per share strength despite reported figures.,Concerns extend beyond a single reporting period, reflecting b...
ASX 200 Today Pro Medicus (ASX:PME) Positioned Within the Shifting ASX Stock Market
September 07, 2025 08:11 PM AEST| By SamHighlights,Pro Medicus gains attention in the ASX stock market due to insider activity,Positioned among ASX Healthcare stocks within the S&P/ASX 200 index,Importance of Pro Medicus within the wider scope of ASX 200 stocks and ASX 200 Companies,Releva...
All ords index EZZ Life Science Holdings (ASX:EZZ) Faces Earnings Quality Challenges
September 06, 2025 03:42 AM AEST| By SamHighlights,EZZ Life Science Holdings reported weak earnings quality, with free cash flow not aligning with accounting,Dilution through new share issuance impacted per-share earnings outcomes,Company is part of the All ords index, increasing its visib...
Healius’s (ASX: HLS) 2025 Special Dividend: A Historic Yield Event for Market Participants
September 05, 2025 05:42 PM AEST| By Team Kalkine MediaDividend yield — a key measure for income-oriented market participants — expresses the cash paid to shareholders relative to the market price of a company’s shares. For steady payers, yields usually mirror sustainable earnings capacity. When yields c...
PheCheck and FebriDx Programs Advance with Global Backing Beyond the ASX 200
September 05, 2025 01:15 PM AEST| By SamLumos Diagnostics (ASX:LDX) strengthens Aptatek and BARDA collaborations to advance PheCheck™ and FebriDx®, highlighting innovation in healthcare diagnostics beyond major ASX indices.
Race Oncology Expands Global RC220 Trial Sites as ASX 200 Sector Watches Oncology Developments
September 05, 2025 12:01 PM AEST| By SamRace Oncology (ASX:RAC) advances its RC220 trial across Australia, Hong Kong, and South Korea, marking a significant oncology milestone within the ASX healthcare and biotech landscape.
Advertise your brand on Kalkine Media